299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

47 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03931252 (ClinicalTrials.gov)	January 2022	25/4/2019	Thermic Effect of Feeding in Cystic Fibrosis	Thermic Effect of Feeding in Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Boost VHC;Dietary Supplement: Ensure High Protein	Virginia Commonwealth University	NULL	Enrolling by invitation	18 Years	N/A	All	10	N/A	United States
2	NCT04938726 (ClinicalTrials.gov)	November 1, 2021	9/6/2021	Ketone Supplementation in Cystic Fibrosis	Ketone Monoester Supplementation in Cystic Fibrosis: A Pilot and Feasibility Study	Cystic Fibrosis	Dietary Supplement: Ketone Monoester	University of Alabama at Birmingham	NULL	Not yet recruiting	18 Years	89 Years	All	25	N/A	NULL
3	NCT04531410 (ClinicalTrials.gov)	July 1, 2021	18/8/2020	NETwork of Linoleic Acid Supplementation in Cystic Fibrosis	Double-blind Randomized Controlled Study of Linoleic Acid Supplementation for 1 Year in Patients With Cystic Fibrosis - Influence on Clinical Status and Metabolism	Cystic Fibrosis	Dietary Supplement: linoleic acid supplementation;Dietary Supplement: oleic acid supplementation	Karolinska Institutet	European Society of Pediatric Gastroenterology, Hepatology and Nutrition	Enrolling by invitation	5 Years	15 Years	All	90	N/A	Italy;Norway;Poland;Sweden
4	NCT04496921 (ClinicalTrials.gov)	August 10, 2020	21/7/2020	Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis	Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis : A Pilot Study	Cystic Fibrosis	Dietary Supplement: Vitamin K supplementation, dose #1;Dietary Supplement: Vitamin K supplementation, dose #2	Institut de Recherches Cliniques de Montreal	Université de Montréal	Withdrawn	18 Years	N/A	All	0	N/A	Canada
5	NCT04166396 (ClinicalTrials.gov)	February 17, 2020	14/11/2019	Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis	Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Resveratrol;Dietary Supplement: NR;Dietary Supplement: Placebo	Virginia Commonwealth University	NULL	Recruiting	18 Years	N/A	All	36	N/A	United States
6	NCT04058340 (ClinicalTrials.gov)	July 30, 2019	12/8/2019	Taste Receptors Regulation in CF Patients	The Effects of Taste Receptors Regulation in Upper Airway Innate Immunity of CF Patients	Cystic Fibrosis	Dietary Supplement: lactizole nebulization;Other: Placebo	Medical Universtity of Lodz	NULL	Recruiting	6 Years	N/A	All	30	N/A	Poland
7	NCT03734744 (ClinicalTrials.gov)	June 17, 2019	6/11/2018	PK/PD of Vitamin D3 in Adults With CF	A Pilot Study Evaluating Single, High-dose Pharmacokinetics/Pharmacodynamics of Vitamin D3 in CF	Vitamin D Deficiency;Cystic Fibrosis	Dietary Supplement: Vitamin D3	University of Southern California	NULL	Suspended	18 Years	N/A	All	12	N/A	United States
8	NCT03710538 (ClinicalTrials.gov)	April 1, 2019	20/6/2018	The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis	The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Snack beverage;Behavioral: Exercise	Institut de Recherches Cliniques de Montreal	NULL	Recruiting	18 Years	N/A	All	14	N/A	Canada
9	NCT04966897 (ClinicalTrials.gov)	August 31, 2018	8/7/2021	Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis	Randomized, Double-blind, Cross-over Trial Assessing a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis	Cystic Fibrosis;Exocrine Pancreatic Insufficiency	Dietary Supplement: GlycosBio Nutritional Supplement + PERT placebo;Dietary Supplement: Standard Nutritional Supplement + PERT	GlycosBio, Inc.	Baylor College of Medicine	Completed	12 Years	N/A	All	10	N/A	United States
10	NCT03462056 (ClinicalTrials.gov)	May 17, 2018	5/3/2018	Ready to Use Therapeutic Food (RUTF) to Promote Growth in Cystic Fibrosis	Pilot Study of Ready to Use Therapeutic Food to Promote Weight Gain in Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Cystic Fibrosis Ready to Use Supplemental Food	Washington University School of Medicine	Cystic Fibrosis Foundation	Completed	2 Years	12 Years	All	16	Phase 1/Phase 2	United States
11	NCT03205904 (ClinicalTrials.gov)	December 12, 2016	15/6/2017	Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.	Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.	Cystic Fibrosis-related Diabetes;Cystic Fibrosis	Dietary Supplement: Diet	Hospital de Clinicas de Porto Alegre	NULL	Completed	10 Years	N/A	All	20	N/A	Brazil
12	NCT02810691 (ClinicalTrials.gov)	July 2016	14/6/2016	The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis	The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis	Cystic Fibrosis-related Diabetes;Cystic Fibrosis	Dietary Supplement: Soluble fiber supplementation;Dietary Supplement: Placebo (for fiber supplementation)	Institut de Recherches Cliniques de Montreal	Canadian Cystic Fibrosis Foundation;Université de Montréal	Completed	18 Years	N/A	All	14	N/A	Canada
13	NCT02646995 (ClinicalTrials.gov)	January 2016	22/12/2015	Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients		Cystic Fibrosis	Dietary Supplement: modified lipid formulation;Dietary Supplement: Fish oil	Nestlé	NULL	Completed	5 Years	18 Years	All	16	N/A	Switzerland
14	NCT02589444 (ClinicalTrials.gov)	December 2015	20/10/2015	Vitamin D and Microbiota in Cystic Fibrosis	Pilot Study Evaluating the Role of Vitamin D Repletion on Gut and Lung Microbiota in Cystic Fibrosis	Vitamin D Deficiency;Cystic Fibrosis	Dietary Supplement: High-Dose Vitamin D3;Other: Stool Sample;Other: Sputum Sample;Other: Sham Comparator;Procedure: Blood draw	Emory University	NULL	Completed	18 Years	N/A	All	41	N/A	United States
15	NCT02518672 (ClinicalTrials.gov)	October 2015	3/8/2015	Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)	Role of DHA Monoglyceride (MAG-DHA) in the Resolution of Pulmonary Inflammation of Patients With Cystic Fibrosis.	Cystic Fibrosis	Dietary Supplement: MAG-DHA;Dietary Supplement: Placebo	SCF Pharma	Centre de recherche du Centre hospitalier universitaire de Sherbrooke;Solutex (Spain)	Terminated	18 Years	N/A	All	11	Phase 2	Canada
16	NCT02690064 (ClinicalTrials.gov)	April 2015	19/2/2016	Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF	Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF	Cystic Fibrosis	Dietary Supplement: Acute Antioxidant;Dietary Supplement: Chronic Antioxidant;Other: Placebo	Augusta University	NULL	Recruiting	7 Years	N/A	All	80	N/A	United States
17	NCT02043717 (ClinicalTrials.gov)	January 2014	12/1/2014	Increased Vitamin D Reduces Pulmonary Exacerbations in CF	Increasing Vitamin D Serum Levels Reduces Pulmonary Exacerbations in Patients With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Vitamin D	Hadassah Medical Organization	NULL	Completed	4 Years	N/A	All	90	N/A	Israel
18	NCT00924547 (ClinicalTrials.gov)	November 2013	17/6/2009	Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis	Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis: Effects on Exhaled Pro-inflammatory Isoprostanes and Analysis of Its Esterification Sites in Plasma	Cystic Fibrosis	Dietary Supplement: Docosahexanoic Acid Supplement;Dietary Supplement: Placebo	Vanderbilt University	NULL	Completed	6 Years	N/A	Both	17	Phase 2	United States
19	NCT01880346 (ClinicalTrials.gov)	October 2013	12/6/2013	Comparison of Absorption of Vitamin D in Cystic Fibrosis	Vehicles for the Absorption of Vitamin D in Cystic Fibrosis: Comparison of Powder vs Oil	Cystic Fibrosis	Dietary Supplement: Vitamin D Powder;Dietary Supplement: Vitamin D Oil	Emory University	NULL	Completed	18 Years	59 Years	Both	17	Phase 4	United States
20	NCT02048592 (ClinicalTrials.gov)	September 2013	16/12/2013	Impact of Immunonutrition on the Patients With Cystic Fibrosis	Impact of Immunonutrition on the Patients With Cystic Fibrosis	Cystic Fibrosis;Malnutrition;Oxidative Stress	Dietary Supplement: Impact -Nutridrink;Dietary Supplement: Nutridrink-Impact	University Hospital, Motol	NULL	Recruiting	18 Years	40 Years	Both	30	Phase 4	Czech Republic
21	NCT01837355 (ClinicalTrials.gov)	March 2013	10/4/2013	Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis	Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Rhamnosus Diet Supplementation in Pediatric Cystic Fibrosis (MoHuM-1)	Pulmonary Inflammation;Cystic Fibrosis;Microbiota	Dietary Supplement: Lactobacillus rhamnosus;Dietary Supplement: Placebo	Cantonal Hospital of St. Gallen	Swiss Federal Institute of Technology;University Hospital Inselspital, Berne	Unknown status	6 Years	20 Years	All	68	N/A	Switzerland
22	NCT02014181 (ClinicalTrials.gov)	July 2012	27/11/2013	Flaxseed Modulates Inflammation and Oxidative Stress in CF	Flaxseed Modulates Oxidative Stress and Inflammatory Biomarkers in Stable Patients With Cystic Fibrosis and Healthy Controls	Cystic Fibrosis;Oxidative Stress;Inflammation	Dietary Supplement: finely ground flaxseed powder	University of Pennsylvania	NULL	Completed	18 Years	64 Years	Both	10	Phase 1	United States
23	NCT01417481 (ClinicalTrials.gov)	March 2012	15/8/2011	Effect of Glycine in Cystic Fibrosis	Evaluation of the Capability of a Glycine Oral Supplement for Diminishing Bronchial Inflammation in Children With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Glycine;Dietary Supplement: Placebo	Instituto Nacional de Enfermedades Respiratorias	Hospital Infantil de Mexico Federico Gomez;Instituto Mexicano del Seguro Social	Terminated	5 Years	15 Years	All	13	Phase 2	Mexico
24	NCT02128984 (ClinicalTrials.gov)	January 2012	28/3/2014	Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children	Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children	Cystic Fibrosis;Failure to Thrive;Malnutrition	Dietary Supplement: Symbiotic Formula with DHA and antioxidants;Dietary Supplement: Standard Formula	Laboratorios Ordesa	Quantum Experimental;Peruvian Clinical Research	Completed	1 Year	N/A	All	109	N/A	Peru;Spain
25	NCT00889434 (ClinicalTrials.gov)	November 1, 2011	20/4/2009	Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)	Single-site, Open-label, Dose-ranging, Efficacy, and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated CF	Cystic Fibrosis	Dietary Supplement: ECGC;Dietary Supplement: Tocotrienol;Dietary Supplement: EGCG + Tocotrienol	Hadassah Medical Organization	NULL	Completed	18 Years	N/A	All	7	N/A	Israel
26	NCT01426256 (ClinicalTrials.gov)	October 2011	29/8/2011	Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)	Vitamin D for Enhancing the Immune System in Cystic Fibrosis	Cystic Fibrosis;Respiratory Tract Infections	Dietary Supplement: Cholecalciferol	Emory University	Cystic Fibrosis Foundation Therapeutics	Completed	16 Years	N/A	All	91	Phase 3	United States
27	NCT01783613 (ClinicalTrials.gov)	October 2011	31/1/2013	Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis	Study of the Eficacy of Long-term Suplementation With Docosahexaenoic Acid on Pulmonary, Sistemic and Intestinal Inflammation in Patients With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Docosahexaenoic acid administration: 50 mg/kg/day during 12 months;Dietary Supplement: Placebo: 50 mg/kg/day during 12 months	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal	NULL	Completed	2 Months	100 Years	All	96	N/A	Spain
28	NCT01315665 (ClinicalTrials.gov)	April 2011	14/3/2011	Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation	Evaluation of the Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation, Measures of Oxidative Stress, and Neutrophil Migration to Mucosal Surfaces in Healthy and CF Subjects	Cystic Fibrosis	Dietary Supplement: Broccoli sprouts	University Hospitals Cleveland Medical Center	Cystic Fibrosis Foundation	Completed	18 Years	49 Years	All	15	N/A	United States
29	NCT02029521 (ClinicalTrials.gov)	March 2011	30/12/2013	Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients	Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis for Growth Failure	Cystic Fibrosis	Dietary Supplement: Oral reduced l-glutathione;Dietary Supplement: Placebo	Clark Bishop	NULL	Completed	18 Months	10 Years	All	47	N/A	Italy
30	NCT01494909 (ClinicalTrials.gov)	January 2011	15/12/2011	Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function	Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function	Cystic Fibrosis	Dietary Supplement: Ensure plus	Texas A&M University	Arkansas Children's Hospital Research Institute;University of Arkansas	Active, not recruiting	10 Years	N/A	All	31	N/A	United States
31	NCT01201434 (ClinicalTrials.gov)	October 2010	31/8/2010	Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis	The Effect of Probiotics on Sputum Bacteria, Sputum Inflammation, and Pulmonary Infections in Patients With Cystic Fibrosis: A Double-blind Placebo-controlled Trial	Cystic Fibrosis	Dietary Supplement: Bio-25 probiotic	Sheba Medical Center	NULL	Terminated	5 Years	40 Years	Both	12	N/A	NULL
32	NCT01956916 (ClinicalTrials.gov)	October 2010	23/9/2013	Probiotics in Cystic Fibrosis	Effects of LGG Administration in Children With Cystic Fibrosis: A Randomized Controlled Trial	Cystic Fibrosis	Dietary Supplement: Lactobacillus rhamnosus GG;Dietary Supplement: placebo	Federico II University	NULL	Completed	2 Years	18 Years	Both	110	Phase 3	Italy
33	NCT01222273 (ClinicalTrials.gov)	September 2010	14/10/2010	Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis	Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis	Cystic Fibrosis;Allergic Bronchopulmonary Aspergillosis	Dietary Supplement: cholecalciferol (Vitamin D3)	University of Pittsburgh	National Heart, Lung, and Blood Institute (NHLBI)	Completed	12 Years	N/A	All	7	N/A	United States
34	NCT01321905 (ClinicalTrials.gov)	April 2010	23/3/2011	Prospective Intervention Study on Vitamin D in Patients With Cystic Fibrosis	5-month Pilot Intervention Study on Vitamin D in Patients With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Supplementation with vitamin D2/D3	Karolinska Institutet	Stockholm County Council, Sweden;Swedish Cystic Fibrosis Association	Recruiting	6 Years	N/A	Both	15	Phase 2	Sweden
35	NCT01051999 (ClinicalTrials.gov)	February 2010	15/1/2010	Glutamine Supplementation in Cystic Fibrosis	Glutamine Supplementation and Immunity in Adults With Cystic Fibrosis	Cystic Fibrosis;Immune Function	Dietary Supplement: Glutamine;Dietary Supplement: L-alanine	Emory University	Emmaus Medical, Inc.	Completed	18 Years	N/A	Both	17	Phase 2	United States
36	NCT01961661 (ClinicalTrials.gov)	September 2009	9/10/2013	Probiotics on Intestinal Inflammation in Cystic Fibrosis	Effect of Probiotics on Intestinal Inflammation and Microflora in Cystic Fibrosis: a Pilot Study	Cystic Fibrosis	Dietary Supplement: Lactobacillus rhamnosus GG;Dietary Supplement: placebo	Federico II University	NULL	Completed	2 Years	18 Years	Both	22	Phase 3	Italy
37	NCT01737983 (ClinicalTrials.gov)	May 2009	12/7/2012	Effect of Lactobacillus Reuteri in Cystic Fibrosis	Lactobacillus Reuteri Reduces Pulmonary Exacerbations and Upper Respiratory Tract Infections in CF Patients With Mild-to-moderate Lung Disease. LR Administration Might Have a Beneficial Effect on the Disease Course of Cystic Fibrosis.	CYSTIC FIBROSIS	Dietary Supplement: Lactobacillus reuteri;Dietary Supplement: placebo	Azienda Policlinico Umberto I	NULL	Completed	6 Years	42 Years	Both	61	Phase 4	Italy
38	NCT00685971 (ClinicalTrials.gov)	December 2008	27/5/2008	Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients	Randomized Placebo-Controlled Trial of Cholecalciferol for Vitamin D Deficiency in Adults With Cystic Fibrosis	Cystic Fibrosis;Vitamin D Deficiency	Dietary Supplement: 5000 IU of cholecalciferol;Dietary Supplement: placebo	St. Michael's Hospital, Toronto	NULL	Completed	18 Years	N/A	Both	200	N/A	Canada
39	NCT00788138 (ClinicalTrials.gov)	October 2008	7/11/2008	Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis		Cystic Fibrosis	Dietary Supplement: Vitamin D3;Dietary Supplement: Placebo	Emory University	NULL	Completed	18 Years	70 Years	Both	30	N/A	United States
40	NCT00959010 (ClinicalTrials.gov)	October 2008	13/8/2009	Omega 3 Supplementation in Cystic Fibrosis Patients	Biochemical Effects of a Long-term Supplementation With Omega-3 Polyunsaturated Fatty Acids in Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: omega-3 triglycerides;Dietary Supplement: Placebo	Queen Fabiola Children's University Hospital	NULL	Completed	6 Years	60 Years	Both	15	Phase 3	Belgium
41	NCT01172301 (ClinicalTrials.gov)	July 2008	27/7/2010	Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis	Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Essential amino acid intake + Leucine vs total AA supplement	Texas A&M University	Arkansas Children's Hospital Research Institute	Completed	10 Years	21 Years	Both	14	N/A	United States
42	NCT00762918 (ClinicalTrials.gov)	March 2008	26/9/2008	Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis	Vitamin D and Its Non-Classic Roles in Cystic Fibrosis	Cystic Fibrosis;Vitamin D Deficiency	Dietary Supplement: cholecalciferol	Children's Hospital of Philadelphia	NULL	Withdrawn	10 Years	25 Years	Both	0	Phase 3	United States
43	NCT01070446 (ClinicalTrials.gov)	October 2007	10/2/2010	Choline Nutrition in Children With Cystic Fibrosis	Choline Nutrition in Children With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1	University of British Columbia	Cystic Fibrosis Foundation (US)	Completed	5 Years	17 Years	Both	34	N/A	Canada
44	NCT01018303 (ClinicalTrials.gov)	August 2007	19/11/2009	Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis	Safety and Efficacy of a Novel Antioxidant-rich Multivitamin Supplement for Persons With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: AquADEK	University of Colorado, Denver	Cystic Fibrosis Foundation Therapeutics;Yasoo Health;National Institutes of Health (NIH)	Completed	10 Years	40 Years	Both	17	Phase 1/Phase 2	United States
45	NCT00406536 (ClinicalTrials.gov)	January 2007	29/11/2006	Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI	Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF	Cystic Fibrosis;Pancreatic Insufficiency	Dietary Supplement: Lym-X-Sorb powder;Dietary Supplement: Placebo powder	Avanti Polar Lipids, Inc.	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	6 Years	17 Years	Both	110	Phase 2	United States
46	NCT00730509 (ClinicalTrials.gov)	April 2004	4/8/2008	Effects of 5-Methyltetrahydrofolate and Vitamin B12 Supplemetation on Red Cell Membrane in Children With Cystic Fibrosis	Preliminary Evidences of Active Form of Folic Acid and Vitamin B12 Supplementation to Ameliorate Cell Membrane in Children With Cystic Fibrosis	Cystic Fibrosis	Dietary Supplement: 5-methyltetrahydrofolate and vitamin B12	Universita di Verona	NULL	Completed	3 Years	8 Years	Both	31	N/A	Italy
47	NCT00530244 (ClinicalTrials.gov)	March 2003	13/9/2007	Use of Formula Fortified With DHA in Infants With Cystic Fibrosis	The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)	Cystic Fibrosis	Dietary Supplement: Docosahexaenoic acid (DHA);Dietary Supplement: Standard formula (Enfamil)	University of Massachusetts, Worcester	Cystic Fibrosis Foundation	Completed	N/A	56 Days	All	76	N/A	United States

先頭へ